| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.3 | 0.06 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.06 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.093 | 0.07 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |